Negre, O., Bartholomä, C. C., Deichmann, A., Fronza, R., Schmidt, M., & Kalle, C. v. (2015). Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease. Current gene therapy, 15(1), . https://doi.org/ 10.2174/1566523214666141127095336
Chicago-Zitierstil (17. Ausg.)Negre, Olivier, Cynthia C. Bartholomä, Annette Deichmann, Raffaele Fronza, Manfred Schmidt, und Christof von Kalle. "Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-thalassemia and Sickle Cell Disease." Current Gene Therapy 15, no. 1 (2015). https://doi.org/ 10.2174/1566523214666141127095336.
MLA-Zitierstil (9. Ausg.)Negre, Olivier, et al. "Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-thalassemia and Sickle Cell Disease." Current Gene Therapy, vol. 15, no. 1, 2015, https://doi.org/ 10.2174/1566523214666141127095336.